Abediterol, a novel long-acting β(2)-agonist: bronchodilation, safety, tolerability and pharmacokinetic results from a single-dose, dose-ranging, active-comparator study in patients with COPD

BACKGROUND: Abediterol is a novel, once-daily long-acting β(2)-agonist in development for the treatment of chronic obstructive pulmonary disease (COPD) and asthma in combination with an anti-inflammatory agent. This Phase IIa, randomised, double-blind, crossover study investigated the bronchodilatio...

Descripción completa

Detalles Bibliográficos
Autores principales: Beier, Jutta, Pujol, Helena, Seoane, Beatriz, Jimenez, Eulalia, Astbury, Carol, Massana, Eric, Ruiz, Sandrine, de Miquel, Gonzalo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4955259/
https://www.ncbi.nlm.nih.gov/pubmed/27439370
http://dx.doi.org/10.1186/s12890-016-0266-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4955259/
https://www.ncbi.nlm.nih.gov/pubmed/27439370
http://dx.doi.org/10.1186/s12890-016-0266-5

Ejemplares similares